Haemophilus influenzae meningitis in Catalonia, Spain: Epidemiology and bacteriologic characteristics

Clinical Microbiology and Infection

Volumn 6, Issue 5, 2000, Pages 279-282

  Latorre, C ^a   Pineda, V ^b   Juncosa, T ^a   Munos C ^a   Dominguez A ^c   Bou, R ^c   Fontanals, D ^b   Sanfeliu, I ^b   Pons, I ^b   Margall, N ^d   Sanchez F ^d   Pericas, R ^d   Lobera, E ^a   Corretger, J M ^e   Majo M ^e   Benet, J ^e   Martinez A ^e   Ciruela, P ^e   Fortea, J ^e   Mirelis, B ^e   Renau, J ^e   Rello, J ^e   Prats, G ^e   Roig, C ^e   Salleras, L I ^e   more..

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Hospital Universitari Parc Taulí   (Spain)

^c GENERALITAT DE CATALUNYA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEPHALOSPORIN; CHLORAMPHENICOL; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD EXAMINATION; CEREBROSPINAL FLUID EXAMINATION; CHILD; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INCIDENCE; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROTYPING; SPAIN; VACCINATION;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 0034191858     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00058-5.x     Document Type: Article

References (19)

1. Wenger JD, Pierce R, Deaver KA et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet 1991; 338: 395-8.
2. Domínguez A, Latorre C, Pineda V et al. Enfermedad invasiva por Haemophilus influenzae tipo b en Cataluña (1996). Med Clin 1999; 112: 5-9.
3. Kayser FH, Morenzoni G, Santmam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1990; 9: 810-17.
4. Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992; 14: 1119-23.
5. National Committee for Clinical Laboratory Standards. Performance standards of antimicrobial susceptibility testing; Eighth Informational Supplement M100-S8 No. 1. Villanova PA: NCCLS, 1998.
6. Ciruela P, Domínguez A, Benet J, Martínez A, Salleras LI. Exhaustivity of reported H. influenzae meningitis in Catalonia (Spain). In: Abstracts of the 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria. European Society of Clinical Microbiology and Infectious Diseases, 1995: 1181.
7. Guallar-Castillóm P, Jiménez FJ, Rubio C, Guallar E. Revisión de los datos de incidencia de enfermedad invasiva y de meningitis por H. influenzae en niños menores de cinco años en España. An Esp Pediatr 1997; 47: 263-8.
8. Pachón I, Muñoz A, Tormo A et al. Estudio de incidencia de enfermedad invasiva por H. influenzae en España. Bol Epidemiol Semanal 1998; 6: 49-52.
9. Booy R, Hodgson SA, Slack MPE, Anderson E, Mayon-White RT, Moxon ER. Invasive H. influenzae type B disease in the Oxford region (1985-91). Arch Dis Child 1993; 69: 225-8.
10. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome Cv. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990; 162: 1316-23.
11. Tsolia MN, Theodoridou MN, Mostrou GJ et al. Epidemiology of invasive H. influenzae type b infections among children in Greece before the introduction of immunization. Scand J Infect Dis 1998; 30: 165-8.
12. Domínguez A, Prats G. Vacuna anti-H. influenzae tipo b. In: Salleras Sanmartí LI, ed. Vacunaciones preventivas. Principios y aplicaciones. Barcelona: Masson, 1998: 311-36.
13. De Juan F, Campos C, Bustillo M, Baldovín I, Bello E, Elviro L. Infecciones invasivas por H. influenzae tipo b en la infancia (1981-90). An Esp Pediatr 1993; 39: 111-15.
14. Takala AK, Eskola J, Peltola H, Makela Ph. Epidemiology of invasive H. influenzae type b disease among children in Finland before vaccination with H. influenzae type b conjugate vaccine. Pediatr Infect Dis J 1989; 8: 297-302.
15. Van Alphen L, Spanjaard L, Dankert J. Non-typable H. influenzae invasive disease. Lancet 1993; 341: 1536.
16. Landgraf IM, Vieira FP. Biotypes and serotypes of H. influenzae from patients with meningitis in the city of Sao Paulo. Brazil J Clin Microbiol 1993; 31: 743-5.
17. Bijlmer HA. World-wide epidemiology of H. influenzae meningitis: industrialized versus nonindustrialized countries. Vaccine 1991; 9(suppl): S5-9.
18. Doern GV, Brueggemann AB, Pierce G, Holley Jr HP, Rauch A. Antibiotic resistance among clinical isolates of H. influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a National Multicenter Surveillance Study. Antimicrob Agents Chemother 1997; 41: 292-7.
19. Perea EJ, García MC, Clavijo MJ et al. Resistencias en H. influenzae en España. Segundo Estudio 1990. Enferm Infecc Microbiol Clin 1993; 11: 19-28.